Answers are grounded in this paper and cite their sources.
-treated astrocytes than in the control astrocytes. Our findings suggest that monitoring the intracellular calcium concentration and metabolic profile can be a valuable approach for detecting early astrocyte dysfunction. The metabolic and neurochemical changes induced by CGRP highlight the potential of astrocyte-targeted strategies for mitigating CGRP-related neurovascular disorders.
No takes yet. Share an insight, caveat, or question.
Phatruengdet et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: